Search Results

Showing results 51 - 60 of 2031.
Sort By: Date ▼

Alexander, Murray just released updated legislation to address 'surprise' medical bills. Here's what made the cut.

June 20, 2019


Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) on Wednesday formally introduced a wide-ranging bill to address so-called "surprise" medical bills that would establish a benchmark provider payment rate for out-of-network services, instead of the arbitration process favored by hospital industry groups.

Pharmacy identifies another cancer-causing chemical in US heart drugs

June 20, 2019


Valisure, an online pharmacy, in a filing to FDA last week said it discovered the carcinogen dimethylformamide in the common heart drug valsartan—marking the fourth carcinogen found in the drug.

How CMS wants to change Medicare Part D prior authorization requirements

June 20, 2019


CMS on Monday proposed a rule intended to streamline Medicare Part D's electronic prior authorization process by circumventing certain HIPAA requirements.

Why these diabetes patients are caravanning to Canada

June 19, 2019


U.S. residents increasingly are visiting Canada to purchase insulin, as costs for the diabetes treatment in the United States have spiked in recent years.

Almost 200 people got expired flu vaccines last season, according to CDC

June 19, 2019


About 169.1 million doses of the seasonal influenza vaccine were administered last flu season, and about 200 patients received expired vaccines—though the real figure might be higher, according to a CDC report published Friday.

Drugmakers sue HHS over rule requiring prices in TV ads

June 17, 2019


Three pharmaceutical companies and the Association of National Advertisers on Friday filed a lawsuit challenging HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, claiming the final rule exceeds HHS' statutory authority and violates the First Amendment of the Constitution.

49 of the most popular drugs saw patient and insurer costs rise between 2012 and 2017, study finds

June 17, 2019


The median total costs insurers and patients paid for the 49 most popular prescription drugs in the United States, by sales, increased between 2012 and 2017, with many of those costs increasing more than twofold, according to a recent study.

Weekly Line: The stem cell industry is booming—and trying to regulate it is 'like playing whack-a-mole'

June 14, 2019


Across the United States, hundreds of clinics are offering stem-cell therapy treatments for everything from joint pain to more serious diseases like Parkinson's and diabetes

CMS OKs Washington's 'subscription' payment model for hepatitis C drugs

June 14, 2019


CMS on Wednesday approved Washington's plan to negotiate value-based drug agreements with the makers of hepatitis C treatments under a subscription-like model.

Results Page: [Previous] ... 6 7 8 9 10  ... [Next]